479 related articles for article (PubMed ID: 11659923)
21. Animal research: a call for legislative reform requiring ethical merit review.
Brody M
HELR Harvard Environ Law Rev; 1989; 13(2):423-84. PubMed ID: 11659214
[No Abstract] [Full Text] [Related]
22. Protection of human subjects.
United States
Code Fed Regul Shipping; 1982 Oct; Part 46, Sections 46.101 to 46.306():. PubMed ID: 11660819
[No Abstract] [Full Text] [Related]
23. The IRB's role in assessing the generalizability of non-NIH-funded clinical trials.
Weijer C
IRB; 1998; 20(2-3):1-5. PubMed ID: 11656912
[No Abstract] [Full Text] [Related]
24. Using the brain dead for medical research.
Martyn SR
Utah Law Rev; 1986; 1986(1):1-28. PubMed ID: 11651917
[No Abstract] [Full Text] [Related]
25. You read it first here!
Crigger BJ
IRB; 1992; 14(5):10-1. PubMed ID: 11659482
[No Abstract] [Full Text] [Related]
26. Research with radiation and healthy children: greater than minimal risk.
Freeman WL
IRB; 1994; 16(5):1-5. PubMed ID: 11652791
[No Abstract] [Full Text] [Related]
27. Federal investigation concludes that institutional review boards are in trouble.
Maloney DM
Hum Res Rep; 1998 Aug; 13(8):1-2. PubMed ID: 11657190
[No Abstract] [Full Text] [Related]
28. Introduction to recombinant DNA research, development and evolution of the NIH guidelines, and proposed legislation.
Talbot B
Univ Toledo Law Rev; 1981; 12(4):804-14. PubMed ID: 11649587
[No Abstract] [Full Text] [Related]
29. The development of policy guidelines governing human experimentation in the United States: a case study of public policy-making for science and technology.
Frankel MS
Ethics Sci Med; 1975 May; 2(1):43-59. PubMed ID: 765128
[No Abstract] [Full Text] [Related]
30. Human experimentation: the review process in practice.
Cowan DH
Case West Reserve Law Rev; 1975; 25(3):533-64. PubMed ID: 11661165
[No Abstract] [Full Text] [Related]
31. Exempt research: procedures in the intramural research program of the National Institutes of Health.
Wichman A; Mills D; Sandler AL
IRB; 1996; 18(2):3-5. PubMed ID: 11654755
[No Abstract] [Full Text] [Related]
32. Gene-splice oversight.
Parens E
Washington Post; 1996 Jun; ():A21. PubMed ID: 11646331
[No Abstract] [Full Text] [Related]
33. Human gene therapy: application, ethics and regulation.
Baskerville G
Dickinson Law Rev; 1992; 96(4):733-63. PubMed ID: 11652212
[No Abstract] [Full Text] [Related]
34. Proposed requirements for informed consent go beyond current federal regulations.
Hum Res Rep; 1994 Jul; 9(7):1-3. PubMed ID: 11659879
[No Abstract] [Full Text] [Related]
35. Half-full or half-empty? Evaluating IRB performance.
Mishkin B; Ariand N
Prof Ethics Rep; 1998; 11(3):4-7. PubMed ID: 11657925
[No Abstract] [Full Text] [Related]
36. Minutes of meeting, 30-31 May 1991.
U.S. National Institutes of Health. Recombinant DNA Advisory Committee
Hum Gene Ther; 1992 Feb; 3(1):95-121. PubMed ID: 11642989
[No Abstract] [Full Text] [Related]
37. A word to Varmus.
Pryor D; Hatfield M; Wyden R; Waxman HA
Hastings Cent Rep; 1996; 26(4):46-7. PubMed ID: 11644858
[No Abstract] [Full Text] [Related]
38. Human Gene Therapy Subcommittee: minutes of meeting, 29-30 Jul 1991.
U.S. National Institutes of Health. Recombinant DNA Advisory Committee. Human Gene Therapy Subcommittee
Hum Gene Ther; 1992 Aug; 3(4):439-55. PubMed ID: 11643020
[No Abstract] [Full Text] [Related]
39. Safety boards must report their conclusions to IRBs.
Maloney DM
Hum Res Rep; 1999 Oct; 14(10):3. PubMed ID: 11658061
[No Abstract] [Full Text] [Related]
40. Informed consent with cognitively impaired patients: an NIMH perspective on the durable power of attorney.
Sunderland T; Dukoff R
Account Res; 1996; 4(3-4):217-26. PubMed ID: 11654517
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
